BMS 181100

Drug Profile

BMS 181100

Alternative Names: BMY 14802; BMY 14802 1; MJ 14802

Latest Information Update: 21 Sep 2000

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Bristol-Myers Squibb
  • Class Anti-infectives; Antiallergics; Antiasthmatics; Antipsychotics; Ischaemic heart disorder therapies
  • Mechanism of Action Opioid receptor antagonists; Serotonin 1A receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Psychotic disorders

Most Recent Events

  • 21 Sep 2000 Discontinued-III for Psychotic disorders in USA (Unknown route)
  • 23 May 1995 Suspended-II for Psychotic disorders in USA (Unknown route)
  • 09 May 1995 A preclinical study has been added to the pharmacodynamics section
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top